Helping create empowered patients
We don’t develop medical treatments - we build digital solutions that address the challenges of the modern patient journey.
Established by LEO Pharma as a small organization, we are built to drive radical innovation to bring our creation to market faster. Our work is enabled by LEO Pharma’s unique ownership structure – owned by the LEO Foundation, with no shareholders, all profits are reinvested to help patients.
OUR BOARD OF DIRECTORS
We are governed by some of Denmark’s leading names in innovation and health tech.
Kristian Hart Hansen, CEO
Under Kristian’s leadership, LEO Innovation Lab has developed a range of innovative digital platforms that enable a more seamless experience for patients within each stage of the clinical journey. Kristian’s vision is to nurture a clinical journey that is more adaptable, patient-driven, and most importantly, more efficient.
Gitte Aabo, CEO & President,
Gitte Aabo has been the Chief Executive Officer and President of LEO Pharma since January 2008. She is Member of the boards of Danmarks Nationalbank (the Danish National Bank), the American Skin Association Board, the American Skin Association Education Council and the European Federation of Pharmaceutical Industries and Associations.
Jakob Jønck, Entrepeneur
Jakob Jønck co-founded health and fitness platform Endomondo in 2007, which went on to be acquired by sports apparel brand Under Armour. An avid athlete and former consultant at McKinsey & Co. Jakob remains an active voice on the global health tech community.
Kim Kjøller, EVP, Global R&D
Kim Kjoeller has over 20 years experience in development and scientific affairs within pharma, holding previous positions at Sanofi and Lundbeck. As part of Kim’s global R&D portfolio, LEO Innovation Lab has thrived to grow several digital patient solutions that enable LEO Pharma to place patients at the centre of every development decision.
HOW WE WORK
Solving problems with unlimited creativity
We look at the problems of everyday life affecting people with skin conditions, and work with patients directly to find solutions that they really need. Then we employ a stringent 100-day build phase to get products and services from the idea stage to market quickly.
Short written description
Description of domain and challenge
Build and find users
Engage with target users
Build MVP (Minimum!)
Test, refine & tests
Plan market experiment
Acquire real users
Prove on smaller scale
Plan growth model
Explore bus. model
Scale growth model
Value tracking (topline, users, data, etc.)
Customer metrics (CAC, churn-rate, etc.)